Dan Barouch

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Dan Hung Barouch (born February 4, 1973) is an American physician, immunologist and virologist, who studies the pathogenesis and immunology of viral infections and works on the development of global vaccine strategies. He authored multiple research and review articles on infectious diseases, viral pathogenesis, immune responses, and vaccine development. Research from Barouch's lab was used in the development of the Johnson & Johnson COVID-19 vaccine. He also worked on vaccine candidates for HIV, Zika, influenza, tuberculosis, and monkeypox.

Dan Hung Barouch (born February 4, 1973) is an American physician, immunologist and virologist, who studies the pathogenesis and immunology of viral infections and works on the development of global vaccine strategies. He authored multiple research and review articles on infectious diseases, viral pathogenesis, immune responses, and vaccine development. Research from Barouch's lab was used in the development of the Johnson & Johnson COVID-19 vaccine. He also worked on vaccine candidates for HIV, Zika, influenza, tuberculosis, and monkeypox.

Research and career

In 2012, Barouch was named the founding director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston. He was appointed the William Bosworth Castle Professor of Medicine at Harvard Medical School in 2020. He is also a founding member and a steering committee member at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University. He is also affiliated with the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery.

HIV research

Barouch began developing vaccine candidates for HIV and other infectious diseases during graduate and medical school, focusing on adjuvanted DNA vaccines and novel adenoviral vectors, including Ad26. In 2000, during medical school, he began researching HIV vaccines and demonstrated that vaccines could reduce viral loads in preclinical models, although immune escape remained a significant challenge. In 2002, he published that an HIV vaccine could suppress the virus for two years in lab animals.

By 2006, he had developed adenoviral vectors that avoided suppression by existing immunity. Barouch's lab developed adenoviral vectors and mosaic proteins (with Bette Korber) that were later incorporated into Johnson & Johnson's HIV vaccine studies. From 2015 to 2018, Barouch co-led the APPROACH study of the Ad26/Env mosaic vaccine in humans and progressed to global efficacy trials in collaboration with partners such as the NIH, the Gates Foundation, and Janssen.

He also explored HIV cure strategies, demonstrating in 2016 and 2018 that combining therapeutic vaccines or broadly neutralizing antibodies with immune activators, also known as the "shock and kill" method, had the potential to be effective.

Zika research

In 2016, Barouch developed and tested the first Zika vaccines in preclinical studies. These vaccines entered first-in-human trials later that year.

Societies and awards

1993: All-USA Academic Team by USA Today. 1999: Graduated with M.D. summa cum laude from Harvard Medical School. 2009: Elected to the American Society for Clinical Investigation. 2012: Awarded the Oswald Avery Award by the Infectious Diseases Society of America. 2016: Named honorary researcher at the Centre de Recherche in the University of Montreal Health Centre (Centre hospitalier de l'Université de Montréal, CHUM) Named Bostonian of the Year by the Boston Globe Magazine. 2020: Elected to the National Academy of Medicine 2021: Awarded the George Ledlie Prize for his work towards the creation of the SARS-CoV-2 vaccine. Awarded the Bostonians of the Year Award by The Boston Globe. 2023: Jointly awarded the 2023 King Faisal Prize for Medicine with vaccinologist Sarah Gilbert. 2025: Elected to the Council of the American Society for Clinical Investigation.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374712299 under CC BY-SA 4.0; modifications have been made.

References

1 claim could not be tied to a specific sentence and is listed in the table below instead.